Pharma BD Deal Intelligence
Roche acquired GenMark Diagnostics for $1.8B for multiplex molecular diagnostics.
Roche agrees to buy GenMark Diagnostics in $1.8 billion deal to expand molecular diagnostics.
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Roche acquired GenMark Diagnostics for $1.8B for multiplex molecular diagnostics.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Roche Holding AG / GenMark Diagnostics (this deal) | 2021 | $1.8B | 61 |
| Roche Holding AG / Chugai Pharmaceutical Co. Ltd. | 2002 | $1.4B | 100 |
| Roche Holding AG / Ventana Medical Systems Inc. | 2008 | $3.4B | 88 |
| Roche Holding AG / Corange Ltd. (Boehringer Mannheim Group) | 1997 | $11.0B | 88 |
| Roche Holding AG / Ventana Medical Systems Inc. | 2007 | $3.4B | 88 |
| Roche Holding AG / Foundation Medicine, Inc. | 2015 | $1.1B | 87 |
| Roche Holding AG / Foundation Medicine, Inc. | 2018 | $5.3B | 85 |
← Browse all deals · How we score deals
More: 2021 deals · Roche Holding AG deals